Western blotting assays showed that the protein expression of RBFOX2 was obviously augmented in NPC biopsies compared with noncancerous samples, as well as in NPC cell lines compared with transformed noncancerous nasopharyngeal cell line (NP69, Figure 5D,E). The gene discussed is RBFOX2; the disease is nasopharyngeal carcinoma.